Aurora Cannabis Inc (OTCMKTS: ACBFF) has seen a spectacular rise in recent years making shareholders who bought this one in 2016 rich today. The stock is the top most traded stock on the entire OTCBB and just announced their plans to list its common shares on the New York Stock Exchange and will commence trading before the end of October 2018.
The booming cannabis space is responsible for many, many huge recent winners. The sector is on fire as we near legal recreational cannabis in Canada on October 17. The global legal marijuana market is expected to reach USD 146.4 billion by end of 2025, according to a new report by Grand View Research, Inc.
Aurora Cannabis Inc (TSE:ACB) (OTCMKTS: ACBFF) is one of the world’s largest and leading cannabis companies with funded capacity in excess of 570,000 kg per year that has been running up the charts as October 17 nears. The BI Canada Cannabis Competitive Peers Index has more than doubled in the past 12 months, though has dropped 24 percent in 2018 on concern that the stocks are overvalued.
Aurora is a Canadian licensed cannabis producer, headquartered in Edmonton. Aurora’s line of products includes whole-flower cannabis, milled cannabis, cannabis oils, and vaporizers. The Company describes itself as one of the world’s largest and leading cannabis companies with funded capacity in excess of 570,000 kg per year and sales and operations in 14 countries across five continents. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.
Aurora has three operational facilities in Canada (Aurora Sky, Aurora Vie, and Aurora Mountain) plus two new facilities projected to be operational by the end of 2018, including a 1,000,000 square foot facility under construction in Odense, Denmark. The Company’s facilities include a 55,200-square-foot production facility in Mountain View County completed in 2015. Aurora Vie is a 40,000-square-foot, fully licensed, indoor production facility in Pointe-Claire, Quebec. It was the second licensed producer in Quebec, and was acquired in 2017 for $7 million. The Company is also currently constructing an automated 800,000-square-foot plant in Alberta that it said would be capable of producing 100,000 kilograms of cannabis annually. The land is part of the acreage owned by the Edmonton International Airport.
Aurora also holds stakes in a leading extraction technology company, Radient Technologies Inc., based in Edmonton, and is in the process of completing an investment in Edmonton-based Hempco Food and Fiber Inc. Aurora is the cornerstone investor in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis. Aurora also owns Pedanios, a leading wholesale importer, exporter, and distributor of medical cannabis in the European Union based in Germany.
Aurora Cannabis was founded by Terry Booth, Steve Dobler, Dale Lesak and Chris Mayerson in 2013. Using much of their own money the group initially secured a 160+ acre parcel of land in Mountain View County, Alberta. The company received its license to grow cannabis as well as its licence to sell medical cannabis both in 2014. The Company’s growth has been fueled by acquisitions and currently the Company’s subsidiaries include Pedanios Gmbh, Germany’s largest distributor of cannabis to pharmacies, CanvasRx, the largest medical cannabis patient outreach service in Canada, BC Northern Lights, an indoor growing supplies manufacturer, Aurora-Larssen Projects, a globally leading greenhouse engineering and design consultancy, and H2 Biopharma, a late-stage ACMPR applicant in Quebec.
To Find out the inside Scoop on Aurora Cannabis Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
Earlier this year Aurora completed their acquisition of Cannimed, with both parties agreeing to the transaction on friendly terms. This agreement brought Aurora’s total patient count to 42,000 registered cannabis patients in Canada. Earlier this year Aurora acquiring rival producer MedReleaf Corp. in a transaction valued at more than $2.5 billion, likely the largest marijuana deal in history. The deal creates an industry giant with production capacity of 570,000 kilograms of cannabis at its nine grow operations in Canada and two in Denmark.
Last month Aurora reported its financial and operational results for the fourth quarter and fiscal year ended June 30, 2018. Aurora reported Revenue of $19,1 million, up 223% compared to the same period in 2017.
Mr. Booth added, “With coast-to-coast supply arrangements, and our strategic investment in Alcanna, we are very well positioned to capitalize on the significant adult consumer use opportunity in Canada. With reported Q4 revenues of $19.1 million, pro-forma Q4 revenues of over $33.1 million, and production capacity scaling up rapidly, we anticipate accelerated revenue growth during fiscal 2019. We have invested heavily in our organizational capabilities, including sales, marketing, and corporate talent and capacity, to ensure we will continue to drive strong and sustainable long-term growth.”
Aurora said last week it has placed its’ 7th order for thousands of MedTainers in anticipation of the mid-October start to Canada’s legal recreational cannabis market. The company states that it anticipated and is well-prepared to fulfill the increased influx of orders for their signature multi-functional, certified child-resistant, FDA-approved container.
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $10 billion market valuation Aurora has $231 million in the treasury and fast growing sales reporting $16.1 million in revenues for the 3 months ended March 31, 2018 up from $5.1 million for the same period last year. Led by Terry Booth, the youngest master electrician on record in Alberta (at 22) Aurora is one of the world’s largest and leading cannabis companies with funded capacity in excess of 570,000 kg per year at its nine grow operations in Canada and Denmark. Aurora said trading in its common shares on the NYSE will commence before the end of October 2018 as ACB. We will be updating on Aurora when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with Aurora.
Sign Up now for our 100% FREE Penny Stock Newsletter
Disclosure: we hold no position in Aurora either long or short and we have not been compensated for this report.